fda safety communication semaglutide naion 2025 GLP-1 Receptor Agonists and vision risk Does Zepbound Cause NAION? Vision

Studies suggest patients taking these medications can lose 15% to 20% of their body weight, on average

Compared with placebo, semaglutide 2.0 mg (risk ratio = 7.73 [95% CI 5.62, 10.63]) and tirzepatide 15 mg (risk ratio = 7.01 [95% CI 5.73, 8.57]) were the most efficacious in achieving an HbA 1c target of 48 mmol/mol (6.5%) (ESM Table 9)

Beyond the clinical implications, the economic burden of obesity and its comorbidities are equally alarming [5, 8]

I had heard good things about Semaglutide, and after some research, it seemed like the right choice for my weight loss journey

The disadvantages are that they are slightly less effective than injections and require daily instead of weekly administration. Novo Nordisk also outlined pricing arrangements they suggest will improve access to the Ozempic pill